Arpakorn KositwattanarerkWirote ChangmuangJatupol SangsuriyanKittiphong ThongklamChanika SritaraChirawat UtamakulWichana ChamroonratKanungnij ThamniratYoch AnongpornyochkulSuporn ChancharuneeMahidol UniversityThailand Institute of Nuclear Technology (Public Organization)2018-10-192018-10-192013-06-13Journal of the Medical Association of Thailand. Vol.96, No.6 (2013), 756-760012522082-s2.0-84878748312https://repository.li.mahidol.ac.th/handle/20.500.14594/32298Radioimmunotherapy (RIT) with131I-rituximab is a safe and effective treatment in patients with relapsed, refractory follicular lymphoma. The authors demonstrated the first case of131I-rituximab treatment in the patient with relapsed non-Hodgkin's lymphoma (NHL) in Thailand. There was no immediate complication after treatment. Impressive treatment response occurred.Mahidol UniversityMedicineArticleSCOPUS